The China National Intellectual Property Administration (CNIPA) and the National Medical Products Administration (NMPA) in the People’s Republic of China (PRC) issued measures to facilitate the implementation of the newly...more
6/7/2021
/ China ,
Chinese Medicine ,
CNIPA ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Patent Applications ,
Patent Registration ,
Patents ,
Pharmaceutical Patents ,
Prescription Drugs